Archive for May, 2010

« Previous Entries

Physiology of hot flashes highlights possible link to cardiovascular risk

Monday, May 17th, 2010

Source: MedWire News
Significant decreases in cardiac vagal control occur in peri- and postmenopausal women during their hot flashes, show study findings.
Previous research has shown a prospective association between reductions in cardiac vagal control and cardiovascular morbidity and mortality, explain Rebecca Thurston and team from the University of Pittsburgh in Pennsylvania, USA.
To investigate further, they measured […]

Scientist Says Anti-Aging Drugs May Be Available In Two Years.

Tuesday, May 11th, 2010

The UK’s Press Association (5/11) reports, “Medicines that can help people live healthy lives to 100 and beyond may be available in as little as two years,” according to “Professor Nir Barzilai, one of the world’s leading age scientists.” The drugs will “involve biological pathways affecting metabolism, cell-death, inflammation and cholesterol.” The Press Association notes […]

Asthma patients at significantly increased risk for anaphylactic shock

Monday, May 10th, 2010

Source: MedWire News
The incidence of anaphylactic shock is significantly higher in people with asthma than in those without the respiratory condition, US study results show.
“Although not all asthma is immunoglobulin (Ig)E mediated, it is a common clinical observation that asthmatic patients are prone to allergic reactions,” comment Carlos Iribarren (Kaiser Permanente Medical Care Program, Oakland, […]

Evidence for CV benefits of inhaled corticosteroids in COPD ‘lacking’

Thursday, May 6th, 2010

Source: MedWire News
A systematic review and meta-analysis of published studies has failed to find strong evidence to suggest that treatment with inhaled corticosteroids (ICSs) reduces risk for myocardial infarction (MI), cardiovascular (CV) death, or overall mortality in patients with chronic obstructive pulmonary disease (COPD).
ICSs are widely used in the treatment of patients with COPD, and […]

Statin use may lower prostate cancer risk recurrence in RT-treated patients

Wednesday, May 5th, 2010

Source: MedWire News
Research indicates that men undergoing radiation therapy (RT) for prostate cancer are more likely to remain relapse free, and less likely to experience biochemical disease recurrence, if they use statins before or during treatment.
However, the research team is unsure whether these improved outcomes are a direct result of the statin therapy itself, or […]

« Previous Entries